Current endovascular treatment of acute ischemic stroke
https://doi.org/10.24884/0042-4625-2024-183-6-64-70
Abstract
Acute ischemic stroke is one of the leading causes of death and long-term disability. For a long time, intravenous thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) has been the only method of treating patients with acute ischemic stroke. However, at present, endovascular treatment allows to achieve better revascularization and good functional outcomes compared with intravenous rt-PA in patients with ischemic stroke due to large vessel occlusion. This article provides an update and discusses the role of endovascular therapy in management of acute ischemic stroke.
About the Authors
D. V. Kandyba
Saint-Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine; Military Medical Academy
Russian Federation
Competing Interests:
Russian Federation
Kandyba Dmitriy V., Cand. of Sci. (Med.), Chief Physician;Assistant of the Department of Neurosurgery
3, Budapeshtskaya str., Saint Petersburg, 192242;6, Academica Lebedeva str., Saint Petersburg, 194044
Competing Interests:
The authors declare no conflict of interest
K. V. Babichev
Saint-Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine; Military Medical Academy
Russian Federation
Competing Interests:
Russian Federation
Babichev Konstantin N., Junior Research Fellow, Doctor; Neurosurgeon, Neurosurgery Clinic
3, Budapeshtskaya str., Saint Petersburg, 192242;6, Academica Lebedeva str., Saint Petersburg, 194044
Competing Interests:
The authors declare no conflict of interest
References
1. Benjamin E. J., Muntner P., Alonso A. et al. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–e528.
2. Roth G. A., Forouzanfar M. H., Moran A. E. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–41. https://doi.org/10.1056/nejmoa1406656.
3. Zeumer H., Hacke W., Ringelstein E. B. Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. AJNR Am J Neuroradiol. 1983;4(3):401–404. PMID: 641075.
4. Alexandrov A. V., Molina C. A., Grotta J. C. et al. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med. 2004; 351:2170–2178. https://doi.org/10.1056/NEJMoa041175.
5. Furlan A., Higashida R., Wechsler L. et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282(21):2003–11.
6. Ischemic stroke and transient ischemic attack in adults. Clinical recommendations. 2021 г. (In russ.).
7. Jovin T. G., Chamorro A., Cobo E. et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372:2296–2306.
8. Saver J. L., Goyal M., Bonafe A. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015; 372:2285–2295.
9. Goyal M., Demchuk A. M., Menon B. K. et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030.
10. Berkhemer O. A., Fransen P. S., Beumer D. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372:11–20.
11. 2015 AHA/ASA Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46:000-000.
12. Nogueira R. G., Jadhav A. P., Haussen D. C. et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N Engl J Med. 2018;378(1):11–21. https://doi.org/10.1056/NEJMoa1706442.
13. Albers G. W., Marks M. P., Kemp S. et al. Thrombectomy for stroke with perfusion imaging selection at 6–16 hours. N Engl J Med. 2018;378:708– 18. https://doi.org/10.1056/NEJMoa1713973.
14. Campbell B. C., Mitchell P. J., Kleinig T. J. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372:1009–1018.
15. Schonewille W. J., Wijman C. A. C., Michel P. et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724–730. https://doi.org/10.1016/S1474-4422(09)70173-5.
16. Liu X., Dai Q., Ye R. et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial. Lancet Neurol. 2020;19:115–122. https://doi.org/10.1016/S1474-4422(19)30395-3.
17. Tao C., Nogueira R. G., Zhu Y. et al. Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion. N Engl J Med. 2022;387(15):1361–1372. https://doi.org/10.1056/NEJMoa2206317.
18. Jovin T. G., Li C., Wu L. et al. Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2022; 387(15):1373–1384. https://doi.org/10.1056/NEJMoa2207576.
19. Langezaal L. C. M., van der Hoeven E. J. R. J., Mont’Alverne F. J. A. et al. Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2021;384(20):1910–1920. https://doi.org/10.1056/NEJMoa2030297.
Supplementary files
Review
For citations:
Kandyba D.V., Babichev K.V. Current endovascular treatment of acute ischemic stroke. Grekov's Bulletin of Surgery. 2024;183(6):64-70. (In Russ.) https://doi.org/10.24884/0042-4625-2024-183-6-64-70
Views:
209
Email this article 